http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8206180-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
filingDate 1981-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1982-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8206180-A1
titleOfInvention A METHOD TO PRODUCE A SOLID PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT IN MICRODOSIS.
abstract METHOD FOR PRODUCING A SOLEDA PHARMACEUTICAL COMPOSITION OF A MICRODOSIS MEDICINAL PRODUCT COVERED BY A WAX. A MEDICINAL PRODUCT IN MICRODOSIS SUCH AS FORMOTEROL FUMARATE OR B-METHYLDIGOXINE IS DISPERSED DIRECTLY IN A MELTED WAX, SUCH AS A HYDROGENATED OIL, AND THE DISPERSION IS COOLED UNDER AGITATION. THE WAX MAY BE DISSOLVED IN A SOLVENT AND SUCH SOLVENT WILL BE SEPARATED. THE ABOVE COMPOSITION IS SUBMITTED TO A GRANULATION OR POWDER FORMATION BY SPRAY FREEZING, VACUUM DRYING OR SPRAY DRYING, AND AN EXCIPIENT IS SUBSEQUENTLY ADDED. LASTLY THE RESULTING COMPOSITION IS FORMULATED IN A SOLID COMPOSITION.
priorityDate 1980-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447947087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501826

Total number of triples: 20.